Sana Biotechnology, Inc. (SANA)

Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	127	133.52	176.77	253.03	124.81	80.03
Short-Term Investments	72.01	71.68	247.2	297.97	253.46	58.95
Cash & Short-Term Investments	199.01	205.2	423.96	551	378.26	138.98
Cash Growth	-25.90%	-51.60%	-23.06%	45.66%	172.17%	353.74%
Prepaid Expenses	7.31	4.49	14.37	7.11	6.2	5.28
Restricted Cash	3.83	3.83	6.1	-	-	-
Total Current Assets	210.15	213.52	444.44	558.1	384.47	144.26
Property, Plant & Equipment	143.87	145.59	159.4	161.78	109.94	68.81
Long-Term Investments	-	-	10.05	195.88	33.73	-
Goodwill	140.63	140.63	140.63	140.63	140.63	140.63
Other Intangible Assets	59.2	59.2	59.2	59.2	59.2	59.2
Other Long-Term Assets	5.56	6.37	9.01	13.82	2.33	2.3
Total Assets	559.39	565.3	822.72	1,129	730.3	415.19
Accounts Payable	2.99	4.11	2.86	2.22	2.25	-
Accrued Expenses	33.21	37.98	39.12	28.91	22.59	9.53
Current Portion of Leases	10.6	13.2	12.39	9.16	3.71	1.34
Other Current Liabilities	0.2	9.2	57.14	58.95	2.89	8.45
Total Current Liabilities	47	64.49	111.5	99.24	31.45	19.32
Long-Term Leases	85.48	90.9	95.86	101.78	68.2	46.36
Other Long-Term Liabilities	134.43	122.41	116.04	199.89	198.94	74.69
Total Liabilities	266.91	277.79	323.41	400.91	298.58	140.38
Common Stock	0.02	0.02	0.02	0.02	0	0
Additional Paid-In Capital	1,848	1,626	1,558	1,515	8.22	1.56
Retained Earnings	-1,556	-1,338	-1,055	-785.36	-429.43	-144.13
Comprehensive Income & Other	0.05	-0.06	-4.33	-1.37	0.03	0.03
Total Common Equity	292.48	287.51	499.32	728.5	-421.18	-142.54
Shareholders' Equity	292.48	287.51	499.32	728.5	431.71	274.82
Total Liabilities & Equity	559.39	565.3	822.72	1,129	730.3	415.19
Total Debt	96.08	104.1	108.25	110.94	71.91	47.7
Net Cash (Debt)	102.92	101.1	325.76	635.93	340.09	91.28
Net Cash Growth	-40.06%	-68.97%	-48.77%	86.99%	272.57%	198.01%
Net Cash Per Share	0.47	0.52	1.73	3.82	26.13	18.62
Filing Date Shares Outstanding	223.27	220.45	191.35	185.18	177.43	10
Total Common Shares Outstanding	223.11	197.86	191.02	184.93	16.17	10
Working Capital	163.15	149.03	332.93	458.87	353.02	124.94
Book Value Per Share	1.31	1.45	2.61	3.94	-26.05	-14.25
Tangible Book Value	92.66	87.68	299.49	528.68	-621.01	-342.36
Tangible Book Value Per Share	0.42	0.44	1.57	2.86	-38.40	-34.23
Machinery	61.69	54.77	64.76	49	30.59	15.68
Construction In Progress	40.23	26.33	1.71	1.39	8.32	3.42
Leasehold Improvements	33.85	31.36	34.43	33.85	15.6	10.62

Source: S&P Capital IQ. Standard template. Financial Sources.